A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer
一项针对转移性胰腺癌患者的 FABLOx(节拍式 5-氟尿嘧啶联合白蛋白紫杉醇、贝伐珠单抗、亚叶酸钙和奥沙利铂)I/II 期开放标签多中心单臂研究
期刊:Journal of Pancreatic Cancer
影响因子:
doi:10.1089/pancan.2019.0012
Sahai, Vaibhav; Saif, M Wasif; Kalyan, Aparna; Philip, Philip A; Rocha-Lima, Caio M; Ocean, Allyson; Ondovik, Michael S; Simeone, Diane M; Banerjee, Sibabrata; Bhore, Rafia; Louis, Chrystal U; Picozzi, Vincent